Asensus Surgical Inc

Asensus Surgical — Transenterix — Investor Day (February 2021)

22 slides from Asensus Surgical's investor day presentation, Feb 23, 2021

  1. Slide 1: Asensus Surgical Investor Day Presentation

    Slide 1: Asensus Surgical Investor Day Presentation

    AASENSUS SURGICAL INVESTOR DAY PRESENTATION February 23, 2021 Anthony Fernando, President & CEO Shameze Rampertab, EVP & CFO

  2. Slide 2: Forward Looking Statements

    Slide 2: Forward Looking Statements

    Forward Looking Statements This presentation includes statements relating to our vision for the future of performance-guided surgery and the role the Senhance® Surgical System may play. These statements and other statements regarding our future plans and goals constitute "forward-looking statements"

  3. Slide 3: Global regulatory approvals, training centers and active surgeon users

    Slide 3: Global regulatory approvals, training centers and active surgeon users

    Fa] & 100+ Global Global ; Regulatory Training Centers Active Surgeon Approvals Users pStcd E fal Active 4,000+ Robust Clinical Sites in Surgeries | |Intellectual Property US, EU & Asia Performed Portfolio 8-8 earn ee ‘8 Strong ie Integrated mca heroes Talented Global Remote Seales soil emma Team Me

  4. Slide 4: Pioneering a new era of Performance-Guided Surgery

    Slide 4: Pioneering a new era of Performance-Guided Surgery

    ASENSUS ci a a ad a Sa a We believe in digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery by unlocking the Clinical Intelligence to enable consistently superior outcomes and a new standard of surgery. -ASENSUS

  5. Slide 5: The Reality of Surgery

    Slide 5: The Reality of Surgery

    The Reality of Surgery 1 in 5 patients undergoing surgery has 1 or more complications* renee Overall profit margin decreased from 5.8% for patients without complications to 0.1% for patients with complications.” Essentially, hospitals make no money if there is a complication. -ASENSUS

  6. Slide 6: Something Missing in the OR

    Slide 6: Something Missing in the OR

    something Missing in the OR Unintended and preventable surgical complications are rampant and cost health systems billions of dollars each year Limited technological innovation (robotics is 20 years old) Lack of access to critical real-time information

  7. Slide 7: Surgical Decision Chain

    Slide 7: Surgical Decision Chain

    Surgical Decision Chain I ———n Prepare Assess Results \ Ns Gather Visual and Surgeon Tactile Data Decision Workflow Leverage Information to Determine Next Action Execute Task SI \ Process & Organize to Generate Insights Decide -ASENSUS

  8. Slide 8: Something is Missing

    Slide 8: Something is Missing

    -ASENSUS Sroncitat Something is Missing Sensing, Analyzing and Deci Minimal innovation to improve decision-making aspects in the high-pressure, highly-variable situations that repeatedly occur during surgery.

  9. Slide 9: We Should Expect More From Surgery

    Slide 9: We Should Expect More From Surgery

    We Should Expect More From Surgery Hol O O O 2) tic approach to addressing each phase of the surgical decision chain Increase safety for better outcomes which lead to better patient and provider satisfaction Reduce surgical variability and factors that contribute to poor outcomes Guide surgeons to s

  10. Slide 10

    Slide 10

  11. Slide 11: Evolution of Surgery

    Slide 11: Evolution of Surgery

    GOAL: Digitize the interface between the surgeon Evolution of Surgery GOAL: Minimize Trauma laparoscopic approach and cost-ffectiveness LAPAROSCOPY DIGITAL LAPAROSCOPY — 1980 2017 PERFORMANCE-GUIDED SURGERY FUTURE GOAL: Minimize Trauma [convert open to minimallyinvasive surgery (MIS) with diferent t

  12. Slide 12: Performance-Guided Surgery

    Slide 12: Performance-Guided Surgery

    Performance-Guided Surgery PERFORMANCE-GUIDED SURGERY Roboti between the and Patient DIGITAL LAF AASENSUS Machine Vision ‘Augmented Intelligence Deep Leaming SCOPY Improved Decision Making Improved Collaboration Ss Improved Predictability

  13. Slide 13: Reimagine Surgery

    Slide 13: Reimagine Surgery

    Reimagine Surgery Technology and the Surgical Value Chain Technology Evolution Surgeon capabilities scale as you add technical capabilities, resulting in increased predictability and superior outcomes Analyze -ASENSUS

  14. Slide 14: Surgical Paradigm

    Slide 14: Surgical Paradigm

    Surgical Paradigm Mapping Categories to the Surgical Value Chain Laparoscopy Manual Coil Robotic Surgery RoboticPrecision and Control Digital Laparoscopy ‘Advanced Sensing, Digital Insights & an erewscen — Performance-Guided Surgery Intetigent Preparation, Perceptive Real-Time Guidance AASENSUS

  15. Slide 15: Technology Video Presentation

    Slide 15: Technology Video Presentation

    Technology Video Presentation

  16. Slide 16: Unlocking Clinical Intelligence: The Surgical Assurance Framework

    Slide 16: Unlocking Clinical Intelligence: The Surgical Assurance Framework

    Unlocking Clinical Intelligence The Surgical Assurance Framework Perceptive Real-Time Guidance + Real-Time, Intra-Op Data + Robotic Intervention + Reduced Cognitive Load Post-Op: Performance Analytics Pre-Op: Fa Intelligent Preparation Performance- *Fj OQ Guided Surgery + Actionable Assessments. ‘Se

  17. Slide 17: aS) i < og (2)

    Slide 17: aS) i < og (2)

    aS) i < og (2)

  18. Slide 18: Market Drivers: Why the Time is Now

    Slide 18: Market Drivers: Why the Time is Now

    -ASENSUS Market Drivers Why the Time is Now Value-based healthcare is rapidly shifting the responsibility for quality outcomesand inefficiency to hospitals and physicians.” Patients’ conditions are becoming more ‘complex and therefore treating them becomes more complicated. The absolute ‘number of p

  19. Slide 19: Global Market Trends in Surgical Robotics

    Slide 19: Global Market Trends in Surgical Robotics

    Global Market Trends in Surgical Robotics ne 198 CAGR ‘WW Surgical Robotics Revenue ($B) | SURGICAL ROBOTICS IS A LARGE AND FAST-GROWING MARKET AND CONVERTING LAPAROSCOPIC SURGERY IS A GREENFIELD OPPORTUNITY AASENSUS Worldwide Robotic PenetrationRate is < 5%, Today ie Other MIS ees | = : Zo robot BB

  20. Slide 20: Our Path to Market Leadership

    Slide 20: Our Path to Market Leadership

    Our Path to Market Leadership Sseriance | 2. : Digital Platform capable of machine vision and augmented intelligence to enable realtime surgical analytics Robust Digital Laparoscopy platform built ‘on the fundamentals of MIS Clinical Inteligence to unlock superior outcomes with surgery Continued foc

  21. Slide 21: Surgery Reimagined

    Slide 21: Surgery Reimagined

    Surgery Reimagined Uy] Ine]

  22. Slide 22: Asensus

    Slide 22: Asensus

    A\ASENSUS

Source: SEC EDGAR · 8-K filed Feb 23, 2021

More decks from Asensus Surgical Inc